The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis

Elizabeth Y. Yuu,Christoph Bührer,Tim Eckmanns,Marcus Fulde,Michaela Herz,Oliver Kurzai,Christin Lindstedt,Gianni Panagiotou,Vitor C. Piro,Aleksandar Radonic,Bernhard Y. Renard,Annicka Reuss,Sara Leal Siliceo,Nadja Thielemann,Andrea Thürmer,Kira van Vorst,Lothar H. Wieler,Sebastian Haller

DOI: https://doi.org/10.1186/s13099-024-00616-w

2024-05-15

Gut Pathogens

Abstract:Enhancing our understanding of the underlying influences of medical interventions on the microbiome, resistome and mycobiome of preterm born infants holds significant potential for advancing infection prevention and treatment strategies. We conducted a prospective quasi-intervention study to better understand how antibiotics, and probiotics, and other medical factors influence the gut development of preterm infants. A controlled neonatal mice model was conducted in parallel, designed to closely reflect and predict exposures. Preterm infants and neonatal mice were stratified into four groups: antibiotics only, probiotics only, antibiotics followed by probiotics, and none of these interventions. Stool samples from both preterm infants and neonatal mice were collected at varying time points and analyzed by 16 S rRNA amplicon sequencing, ITS amplicon sequencing and whole genome shotgun sequencing.

gastroenterology & hepatology,microbiology

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to explore the impact of medical interventions (such as antibiotics and probiotics) on the gut microbiome, resistome, and mycobiome of preterm infants, and to investigate whether these interventions significantly affect infection prevention and treatment strategies for preterm infants.

Specifically, the paper examines how medical factors like antibiotics and probiotics influence the gut development of preterm infants through a prospective quasi-intervention study. Additionally, a controlled neonatal mouse model was designed for parallel research. Preterm infants and neonatal mice were divided into four groups: antibiotics only, probiotics only, antibiotics followed by probiotics, and no intervention. The study analyzed fecal samples using 16S rRNA amplicon sequencing, ITS amplicon sequencing, and whole-genome shotgun sequencing to assess the impact of different interventions on the gut microbiome, resistome, and mycobiome.